Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Ebinger
Timothy D Henry

Showing results (371-380 of 605) with videos related to

Pageof 61
Sort By:
Plos Medicine|March 26, 2026
Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trialsEliano P Navarese, Paul Gurbel, Udaya Tantry, et al.
American Heart Journal|May 28, 2013
Developing an ST-elevation myocardial infarction system of care in Dallas CountyJami DelliFraine, James Langabeer, Wendy Segrest, et al.
JAMA|January 9, 2019
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialTracy Y Wang, Lisa A Kaltenbach, Christopher P Cannon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2019
Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: the Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trialTarun Chakravarty, Timothy D Henry, Michelle Kittleson, et al.
Prehospital and Disaster Medicine|May 21, 2020
The Effect of Implementation of the American Heart Association Mission Lifeline PreAct Algorithm for Prehospital Cardiac Catheterization Laboratory Activation on the Rate of "False Positive" ActivationsJuliana Tolles, Nichole Bosson, Amy H Kaji, et al.
Circulation|April 25, 2012
Has the time come for a national cardiovascular emergency care system?Kevin J Graham, Craig E Strauss, Lori L Boland, et al.
JACC. Cardiovascular Imaging|January 16, 2022
Reproducibility of CMR in Patients With Cardiac Implantable Electrical Devices: Multicenter CONCERT-HF TrialMohammad R Ostovaneh, Caroline Ward, Bharath Ambale-Venkatesh, et al.
Circulation. Cardiovascular Quality and Outcomes|May 24, 2012
Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: LifelineJames G Jollis, Christopher B Granger, Timothy D Henry, et al.
Journal of the American College of Cardiology|February 4, 2014
Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary interventionTracy Y Wang, Lisa McCoy, Timothy D Henry, et al.
American Heart Journal|July 5, 2021
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerationsThomas J Povsic, Timothy D Henry, E Magnus Ohman, et al.
Pageof 61

Showing results (371-380 of 605) with videos related to

Sort By:
Pageof 61
Plos Medicine|March 26, 2026
Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trialsEliano P Navarese, Paul Gurbel, Udaya Tantry, et al.
American Heart Journal|May 28, 2013
Developing an ST-elevation myocardial infarction system of care in Dallas CountyJami DelliFraine, James Langabeer, Wendy Segrest, et al.
JAMA|January 9, 2019
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialTracy Y Wang, Lisa A Kaltenbach, Christopher P Cannon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2019
Allogeneic cardiosphere-derived cells for the treatment of heart failure with reduced ejection fraction: the Dilated cardiomYopathy iNtervention with Allogeneic MyocardIally-regenerative Cells (DYNAMIC) trialTarun Chakravarty, Timothy D Henry, Michelle Kittleson, et al.
Prehospital and Disaster Medicine|May 21, 2020
The Effect of Implementation of the American Heart Association Mission Lifeline PreAct Algorithm for Prehospital Cardiac Catheterization Laboratory Activation on the Rate of "False Positive" ActivationsJuliana Tolles, Nichole Bosson, Amy H Kaji, et al.
Circulation|April 25, 2012
Has the time come for a national cardiovascular emergency care system?Kevin J Graham, Craig E Strauss, Lori L Boland, et al.
JACC. Cardiovascular Imaging|January 16, 2022
Reproducibility of CMR in Patients With Cardiac Implantable Electrical Devices: Multicenter CONCERT-HF TrialMohammad R Ostovaneh, Caroline Ward, Bharath Ambale-Venkatesh, et al.
Circulation. Cardiovascular Quality and Outcomes|May 24, 2012
Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: LifelineJames G Jollis, Christopher B Granger, Timothy D Henry, et al.
Journal of the American College of Cardiology|February 4, 2014
Early post-discharge bleeding and antiplatelet therapy discontinuation among acute myocardial infarction patients treated with percutaneous coronary interventionTracy Y Wang, Lisa McCoy, Timothy D Henry, et al.
American Heart Journal|July 5, 2021
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerationsThomas J Povsic, Timothy D Henry, E Magnus Ohman, et al.
Pageof 61